Monday, 11 July 2022

Dr. Reddys Laboratories announces the launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. market

Dr. Reddys Laboratories announces the launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. market
Fesoterodine Fumarate Extended-Release Tablets in the U.S. market

Dr. Reddys Laboratories Ltd is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Dr. Reddys offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.

admin Mon, 07/11/2022 - 15:27

source https://www.pharmatutor.org/pharma-news/2022/dr-reddys-laboratories-announces-the-launch-of-fesoterodine-fumarate-extended-release-tablets-in-the-us-market

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...